Product Benefits

• Dual-Action Airway Control: Combines two medications to manage symptoms: Budesonide (corticosteroid) reduces inflammation and swelling in the lungs, and Formoterol (long-acting bronchodilator) relaxes the muscles around the airways to keep them open for up to 12 hours.

• Effective Maintenance Therapy: Indicated for the regular and long-term control of moderate-to-severe asthma and COPD, significantly reducing the frequency and severity of flare-ups (exacerbations).

• Improved Lung Function: Consistent use helps improve breathing, reduce wheezing, chest tightness, and shortness of breath, leading to a better quality of life for patients with chronic respiratory illness.

• Rapid Onset of Action: Formoterol provides a rapid onset of bronchodilation (within 1-3 minutes), which is advantageous for quick symptom improvement even in a maintenance regimen.

• CFC-Free Formulation: Often a hydrofluoroalkane (HFA) propellant inhaler, making it an environmentally friendlier alternative compared to older CFC inhalers.